Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cryptosporidiosis - Overview
Cryptosporidiosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cryptosporidiosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cryptosporidiosis - Companies Involved in Therapeutics Development
AbbVie Inc
Aviex Technologies LLC
Epichem Pty Ltd
ioGenetics Inc
Novartis AG
Cryptosporidiosis - Drug Profiles
AV-0215W - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AV-0216W - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
clofazimine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DBAF-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EPLAJ-1317 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KDU-731 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit CDPK1 for Protozoal Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cryptosporidiosis - Dormant Projects
Cryptosporidiosis - Discontinued Products
Cryptosporidiosis - Product Development Milestones
Featured News & Press Releases
Mar 14, 2018: Calibr’s repurposed drug to treat non-viral diarrhea enters into a clinical trial
Feb 14, 2018: Novartis forms alliance to develop medicines for treating infectious diarrheal disease
May 31, 2017: Progress reported in global fight against diarrheal disease cryptosporidiosis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Cryptosporidiosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Cryptosporidiosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Cryptosporidiosis - Pipeline by AbbVie Inc, H2 2020
Cryptosporidiosis - Pipeline by Aviex Technologies LLC, H2 2020
Cryptosporidiosis - Pipeline by Epichem Pty Ltd, H2 2020
Cryptosporidiosis - Pipeline by ioGenetics Inc, H2 2020
Cryptosporidiosis - Pipeline by Novartis AG, H2 2020
Cryptosporidiosis - Dormant Projects, H2 2020
Cryptosporidiosis - Discontinued Products, H2 2020